{"id":1848,"date":"2026-06-27T12:34:23","date_gmt":"2026-06-27T11:34:23","guid":{"rendered":"http:\/\/seamlessbio.de\/?page_id=1848"},"modified":"2026-06-27T12:36:00","modified_gmt":"2026-06-27T11:36:00","slug":"fbs-for-pharma","status":"publish","type":"page","link":"https:\/\/seamlessbio.de\/de\/fbs-for-pharma\/","title":{"rendered":"Application FBS for Pharma"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-page\" data-elementor-id=\"1848\" class=\"elementor elementor-1848\" data-elementor-post-type=\"page\">\n\t\t\t\t<div class=\"elementor-element elementor-element-d334062 e-con e-atomic-element e-flexbox-base e-aa3c270 \" data-id=\"d334062\" data-element_type=\"e-flexbox\" data-e-type=\"e-flexbox\" data-interaction-id=\"d334062\">\n    \t\t<div class=\"elementor-element elementor-element-42f9275 elementor-widget elementor-widget-html\" data-id=\"42f9275\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"html.default\">\n\t\t\t\t\t<!-- YOAST SEO SETTINGS\nSlug:             applications\/fbs-for-pharma\nFocus Keyword:    FBS pharmaceutical GMP Ph. Eur. EMEA Australian US origin gamma irradiated\nSEO Title (EN):   FBS for Pharmaceutical Applications \u2014 Ph. Eur. & EMEA Tested | SeamlessBio\nMeta Desc (EN):   Pharmaceutical-grade FBS. US, Australian, NZ, EU origin. Ph. Eur. 2.6.1\/2.6.7\/2.6.14, ICH Q5A viral safety. Gamma irradiation, Tet-Free, Heat Inactivated. GMP documentation. Batch reservation.\n-->\n<section class=\"sb-app\">\n<style>\n.sb-app,.sb-app *,.sb-app *::before,.sb-app *::after{box-sizing:border-box;}\n.sb-app{background:#fff;padding:70px 40px 90px;font-family:Arial,sans-serif;color:#202020;}\n.sb-app .wrap{max-width:1200px;width:100%;margin:0 auto;}\n.sb-app .bc{display:flex;flex-wrap:wrap;gap:8px;margin:0 0 24px;color:#777;font-size:14px;}\n.sb-app .bc a{color:#18b7b2!important;text-decoration:none!important;font-weight:700;}\n.sb-app .bc strong{color:#111;font-weight:800;}\n.sb-app .hero{padding:64px 56px;margin-bottom:48px;border-radius:30px;background:linear-gradient(135deg,#18b7b2 0%,#65d3cf 52%,#e9fbfa 100%);color:#fff;}\n.sb-app .hero .ey{display:inline-block;margin-bottom:14px;font-size:13px;font-weight:900;text-transform:uppercase;letter-spacing:1.8px;}\n.sb-app .hero h1{margin:0 0 18px;color:#fff;font-size:clamp(26px,3.2vw,40px);line-height:1.1;font-weight:900;letter-spacing:-1px;max-width:840px;}\n.sb-app .hero .sub{max-width:720px;margin:0 0 30px;color:#fff;font-size:17px;line-height:1.65;}\n.sb-app .hbtns{display:flex;flex-wrap:wrap;gap:14px;}\n.sb-app .btn1{display:inline-flex;align-items:center;justify-content:center;min-height:46px;padding:0 28px;border-radius:999px;background:#18b7b2;color:#fff!important;text-decoration:none!important;text-transform:uppercase;font-size:13px;font-weight:900;letter-spacing:.6px;transition:all .25s;}\n.sb-app .btn1:hover{background:#139b97;transform:translateY(-2px);}\n.sb-app .btn2{display:inline-flex;align-items:center;justify-content:center;min-height:46px;padding:0 28px;border-radius:999px;background:transparent;border:2px solid #fff;color:#fff!important;text-decoration:none!important;text-transform:uppercase;font-size:13px;font-weight:900;letter-spacing:.6px;transition:all .25s;}\n.sb-app .btn2:hover{background:#fff;color:#139b97!important;transform:translateY(-2px);}\n.sb-app .sec{margin-bottom:34px;padding:34px;border-radius:26px;background:#fff;border:1px solid #eee;}\n.sb-app .sec h2{margin:0 0 14px;color:#111;font-size:22px;font-weight:900;}\n.sb-app .sec p{margin:0 0 12px;color:#555;font-size:15px;line-height:1.7;}\n.sb-app .tw{overflow-x:auto;margin-top:16px;}\n.sb-app table{width:100%;border-collapse:collapse;font-size:14px;min-width:480px;}\n.sb-app thead th{background:#18b7b2;color:#fff;padding:11px 13px;text-align:left;font-weight:700;}\n.sb-app tbody tr:nth-child(even){background:#f5fffe;}\n.sb-app tbody tr:hover{background:#e8f9f8;}\n.sb-app tbody td{padding:10px 13px;vertical-align:top;border-bottom:1px solid #e5e5e5;line-height:1.5;font-size:13px;}\n.sb-app table a{color:#18b7b2;text-decoration:none;font-weight:600;}\n.sb-app .ok{color:#18b7b2;font-weight:700;}\n.sb-app .faq{margin-bottom:34px;padding:34px;border-radius:26px;background:#f7fbfb;border:1px solid rgba(24,183,178,.18);}\n.sb-app .faq h2{margin:0 0 20px;color:#111;font-size:22px;font-weight:900;}\n.sb-app .faq-item{border-bottom:1px solid #e0e0e0;padding:18px 0;}\n.sb-app .faq-item:last-child{border-bottom:none;padding-bottom:0;}\n.sb-app .faq-q{font-size:15px;font-weight:900;color:#111;margin-bottom:8px;}\n.sb-app .faq-a{font-size:14px;color:#555;line-height:1.7;}\n.sb-app .related{margin-bottom:34px;padding:28px 34px;border-radius:26px;background:#f7fbfb;border:1px solid rgba(24,183,178,.18);}\n.sb-app .related h3{margin:0 0 16px;color:#111;font-size:18px;font-weight:900;}\n.sb-app .rel-grid{display:grid;grid-template-columns:repeat(2,1fr);gap:12px;}\n.sb-app .rel-grid a{display:flex;align-items:center;min-height:50px;padding:12px 16px;border-radius:12px;background:#fff;border:1px solid #e0e0e0;color:#111!important;text-decoration:none!important;font-size:13px;font-weight:700;transition:all .2s;}\n.sb-app .rel-grid a:hover{border-color:#18b7b2;color:#139b97!important;}\n.sb-app .hub-back{text-align:center;padding:20px 0 0;border-top:1px solid rgba(24,183,178,.15);margin-bottom:16px;}\n.sb-app .hub-back a{color:#18b7b2;font-size:14px;font-weight:700;text-decoration:none;}\n.sb-app .cta{padding:54px 34px;border-radius:30px;background:#f7fbfb;border:1px solid rgba(24,183,178,.18);text-align:center;}\n.sb-app .cta h2{margin:0 0 12px;color:#111;font-size:28px;font-weight:900;}\n.sb-app .cta p{max-width:760px;margin:0 auto 26px;color:#555;font-size:15px;line-height:1.65;}\n.sb-app .ctabtns{display:flex;flex-wrap:wrap;gap:14px;justify-content:center;}\n.sb-app .ctab1,.sb-app .ctab2{display:inline-flex;align-items:center;justify-content:center;min-height:46px;padding:0 28px;border-radius:999px;font-size:13px;font-weight:900;text-transform:uppercase;letter-spacing:.6px;text-decoration:none!important;transition:all .25s;}\n.sb-app .ctab1{background:#18b7b2;color:#fff!important;}\n.sb-app .ctab1:hover{background:#139b97;transform:translateY(-2px);}\n.sb-app .ctab2{background:transparent;border:2px solid #18b7b2;color:#18b7b2!important;}\n.sb-app .ctab2:hover{background:#18b7b2;color:#fff!important;transform:translateY(-2px);}\n@media(max-width:1100px){.sb-app .hero{padding:48px 36px;}.sb-app .rel-grid{grid-template-columns:1fr;}}\n@media(max-width:700px){.sb-app{padding:50px 16px 70px;}.sb-app .hero{padding:40px 24px;border-radius:24px;}.sb-app .hero h1{font-size:25px;}.sb-app .hbtns,.sb-app .ctabtns{flex-direction:column;}.sb-app .btn1,.sb-app .btn2,.sb-app .ctab1,.sb-app .ctab2{width:100%;}.sb-app .sec,.sb-app .faq{padding:20px;}.sb-app .cta{padding:36px 20px;}}\n<\/style>\n<div class=\"wrap\">\n  <div class=\"bc\">\n    <a href=\"http:\/\/seamlessbio.de\/\">Home<\/a><span>\/<\/span>\n    <a href=\"https:\/\/www.seamlessbio.de\/applications\/\">Applications<\/a><span>\/<\/span>\n    <strong>FBS for Pharmaceutical Use<\/strong>\n  <\/div>\n  <div class=\"hero\">\n    <span class=\"ey\">SeamlessBio \u2014 Ph. Eur. \u00b7 ICH Q5A \u00b7 GMP Documentation \u00b7 Batch Reservation<\/span>\n    <h1>Fetal Bovine Serum for Pharmaceutical Applications \u2014 Ph. Eur. &amp; EMEA Tested<\/h1>\n    <p class=\"sub\">Pharmaceutical manufacturing and GMP-grade bioprocessing place significantly higher demands on FBS than research applications. Regulatory submissions require documented serum origin, adventitious agent testing to Ph. Eur. and USP standards, TSE risk assessment, and lot reservation to ensure manufacturing consistency from process development through clinical batch production.<\/p>\n    <div class=\"hbtns\">\n      <a href=\"https:\/\/www.seamlessbio.de\/about-us\/contact-imprint\/\" class=\"btn1\">Contact Us<\/a>\n      <a href=\"https:\/\/shop.seamlessbio.de\" class=\"btn2\">View in Shop<\/a>\n    <\/div>\n  <\/div>\n\n  <!-- ORIGINS -->\n  <div class=\"sec\">\n    <h2>Available Origins<\/h2>\n    <div class=\"tw\">\n      <table>\n        <thead><tr><th>Origin<\/th><th>TSE Risk Classification<\/th><th>Primary Use Case<\/th><\/tr><\/thead>\n        <tbody>\n          <tr><td><strong>United States<\/strong><\/td><td>USDA-regulated; negligible BSE risk per EMA\/CHMP\/BWP<\/td><td>FDA IND\/BLA submissions; US-origin preference for USFDA-regulated products<\/td><\/tr>\n          <tr><td><strong>Australia<\/strong><\/td><td>Negligible BSE risk; APVMA-regulated<\/td><td>EMA submissions; lowest TSE risk documentation burden; preferred for EU MAA<\/td><\/tr>\n          <tr><td><strong>New Zealand<\/strong><\/td><td>Negligible BSE risk; MPI-regulated<\/td><td>EMA submissions; equivalent TSE profile to Australia; EU MAA preferred<\/td><\/tr>\n          <tr><td><strong>EU Origin<\/strong><\/td><td>Controlled BSE risk; EU-regulated herd surveillance<\/td><td>EMA submissions requiring EU-origin preference; simplified import documentation for DACH customers<\/td><\/tr>\n        <\/tbody>\n      <\/table>\n    <\/div>\n  <\/div>\n\n  <!-- PHARMA SPECIFICATIONS -->\n  <div class=\"sec\">\n    <h2>Pharmaceutical-Grade Specifications<\/h2>\n    <div class=\"tw\">\n      <table>\n        <thead><tr><th>Parameter<\/th><th>Standard<\/th><th>Available Grade<\/th><\/tr><\/thead>\n        <tbody>\n          <tr><td><strong>Sterility<\/strong><\/td><td>Ph. Eur. 2.6.1 \/ USP &lt;71&gt;<\/td><td>All pharma-grade lots<\/td><\/tr>\n          <tr><td><strong>Mycoplasma<\/strong><\/td><td>Ph. Eur. 2.6.7 \/ USP &lt;63&gt;<\/td><td>All pharma-grade lots<\/td><\/tr>\n          <tr><td><strong>Endotoxin (LAL)<\/strong><\/td><td>Ph. Eur. 2.6.14 \/ USP &lt;85&gt;<\/td><td>&lt;1 EU\/mL (Low Endotoxin grade)<\/td><\/tr>\n          <tr><td><strong>Viral safety (BVDV, BVV)<\/strong><\/td><td>Ph. Eur. 5.2.3 \/ ICH Q5A<\/td><td>Lot-specific viral testing; PCR and infectivity methods<\/td><\/tr>\n          <tr><td><strong>Haemoglobin<\/strong><\/td><td>Spectrophotometric<\/td><td>&lt;20 mg\/dL standard; lower on request<\/td><\/tr>\n          <tr><td><strong>Gamma irradiation<\/strong><\/td><td>\u226525 kGy minimum absorbed dose<\/td><td>On request; dose mapping certificate included<\/td><\/tr>\n          <tr><td><strong>Heat inactivation<\/strong><\/td><td>56\u00b0C \/ 30 min<\/td><td>On request; complement activity confirmed &lt;10%<\/td><\/tr>\n        <\/tbody>\n      <\/table>\n    <\/div>\n  <\/div>\n\n  <!-- DOCUMENTATION -->\n  <div class=\"sec\">\n    <h2>Documentation Package<\/h2>\n    <p>Every pharmaceutical-grade FBS lot includes a complete documentation package aligned with EMA CHMP\/BWP and FDA regulatory expectations:<\/p>\n    <div class=\"tw\">\n      <table>\n        <thead><tr><th>Document<\/th><th>SeamlessBio<\/th><th>Regulatory Requirement<\/th><\/tr><\/thead>\n        <tbody>\n          <tr><td>Certificate of Analysis (CoA)<\/td><td class=\"ok\">\u2705 Per lot<\/td><td>FDA 21 CFR Part 211, EMA Eudralex Vol. 4<\/td><\/tr>\n          <tr><td>Certificate of Origin (CoO)<\/td><td class=\"ok\">\u2705 Per lot<\/td><td>Raw material traceability<\/td><\/tr>\n          <tr><td>TSE\/BSE Risk Assessment<\/td><td class=\"ok\">\u2705 Per lot<\/td><td>EMA CHMP\/BWP\/457920\/2012<\/td><\/tr>\n          <tr><td>Viral Safety Testing Report<\/td><td class=\"ok\">\u2705 Per lot \u2014 BVDV, BVV, REO-3 per Ph. Eur. 5.2.3<\/td><td>ICH Q5A \u2014 viral safety of biological raw materials<\/td><\/tr>\n          <tr><td>Gamma Irradiation Certificate<\/td><td class=\"ok\">\u2705 On request \u2014 irradiator validation, dose mapping, absorbed dose confirmation<\/td><td>Single-use bag sterility documentation<\/td><\/tr>\n          <tr><td>Animal-Derived Components Declaration (ADCD)<\/td><td class=\"ok\">\u2705 On request<\/td><td>For regulatory submissions requiring ADCD<\/td><\/tr>\n          <tr><td>Batch reservation<\/td><td class=\"ok\">\u2705 12\u201336 months for ATMP\/GMP manufacturing campaigns<\/td><td>Process validation \u2014 same lot for entire campaign<\/td><\/tr>\n        <\/tbody>\n      <\/table>\n    <\/div>\n  <\/div>\n\n  <!-- SPECIALTY GRADES -->\n  <div class=\"sec\">\n    <h2>Available Specialty Grades for Pharma<\/h2>\n    <div class=\"tw\">\n      <table>\n        <thead><tr><th>Grade<\/th><th>Key Specification<\/th><th>Pharma Application<\/th><\/tr><\/thead>\n        <tbody>\n          <tr><td><a href=\"https:\/\/www.seamlessbio.de\/products\/fetal-bovine-serum\/fbs-low-very-low-endotoxin\"><strong>FBS Low Endotoxin<\/strong><\/a><\/td><td>&lt;1 EU\/mL<\/td><td>GMP cell culture; minimises pyrogenic risk in manufacturing media<\/td><\/tr>\n          <tr><td><a href=\"https:\/\/www.seamlessbio.de\/products\/fetal-bovine-serum\/fbs-gamma-irradiated\"><strong>FBS Gamma Irradiated<\/strong><\/a><\/td><td>\u226525 kGy, dose-mapped<\/td><td>BSL-2\/3 viral vaccine production; enhanced viral safety margin<\/td><\/tr>\n          <tr><td><a href=\"https:\/\/www.seamlessbio.de\/products\/fetal-bovine-serum\/fbs-tet-free\"><strong>FBS Tet-Free<\/strong><\/a><\/td><td>Tetracycline &lt;10 ng\/mL<\/td><td>Inducible expression systems (AAV, lentiviral packaging, CAR-T)<\/td><\/tr>\n          <tr><td><a href=\"https:\/\/www.seamlessbio.de\/products\/fetal-bovine-serum\/fbs-ultra-low-igg-low-igg\"><strong>FBS Ultra Low IgG<\/strong><\/a><\/td><td>IgG &lt;5 \u00b5g\/mL<\/td><td>Downstream purification \u2014 reduces bovine IgG co-elution on Protein A columns<\/td><\/tr>\n          <tr><td><a href=\"https:\/\/www.seamlessbio.de\/products\/fetal-bovine-serum\/fbs-heat-inactivated\"><strong>FBS Heat Inactivated<\/strong><\/a><\/td><td>56\u00b0C \/ 30 min<\/td><td>Complement-sensitive manufacturing processes; T cell expansion<\/td><\/tr>\n        <\/tbody>\n      <\/table>\n    <\/div>\n  <\/div>\n\n  <!-- FAQ -->\n  <div class=\"faq\">\n    <h2>Frequently Asked Questions<\/h2>\n    <div class=\"faq-item\">\n      <div class=\"faq-q\">Which FBS origin is preferred for EMA submissions?<\/div>\n      <div class=\"faq-a\">Australian and New Zealand origin FBS carries the strongest TSE\/BSE documentation for EMA submissions \u2014 both countries are classified as OIE Negligible Risk with no indigenous BSE. EDQM CEP is available for both origins. EU-origin FBS is also accepted and can simplify import documentation for DACH-based manufacturers. US-origin FBS (USDA 9CFR) is preferred for FDA IND\/BLA submissions.<\/div>\n    <\/div>\n    <div class=\"faq-item\">\n      <div class=\"faq-q\">How long can I reserve a pharmaceutical FBS lot?<\/div>\n      <div class=\"faq-a\">SeamlessBio offers batch reservation for 12\u201336 months for ATMP, GMP manufacturing, and clinical vaccine production programmes \u2014 covering the full journey from process development through Phase I\/II clinical batch production. This ensures the same lot specification throughout the campaign without risk of gap or lot change that would trigger process re-validation.<\/div>\n    <\/div>\n    <div class=\"faq-item\">\n      <div class=\"faq-q\">Is gamma-irradiated FBS required for GMP viral vaccine production?<\/div>\n      <div class=\"faq-a\">Gamma irradiation (\u226525 kGy) is not universally mandated but is increasingly specified for GMP viral vaccine production in BSL-2\/3 facilities to provide an additional assurance of viral safety beyond standard adventitious agent testing. SeamlessBio provides gamma-irradiated FBS with full dose mapping certificate and validation documentation per ISO 11137. This is also specified in some WHO and ICH Q5A-aligned FBS procurement guidelines.<\/div>\n    <\/div>\n    <div class=\"faq-item\">\n      <div class=\"faq-q\">Why is FBS Tet-Free needed for inducible expression systems?<\/div>\n      <div class=\"faq-a\">Standard FBS contains tetracycline residues at 10\u2013100 ng\/mL from routine antibiotic use in bovine husbandry. Tet-On and Tet-Off inducible promoter systems \u2014 used in AAV packaging cell lines, lentiviral vector production, and CAR-T construct systems \u2014 are suppressed by tetracycline at concentrations as low as 1\u201310 ng\/mL. Standard FBS can partially or completely suppress inducible transgene expression, causing researchers to incorrectly conclude their construct is non-functional. FBS Tet-Free &lt;10 ng\/mL is mandatory for any Tet-regulated application.<\/div>\n    <\/div>\n  <\/div>\n\n  <div class=\"related\">\n    <h3>Related Applications &amp; Products<\/h3>\n    <div class=\"rel-grid\">\n      <a href=\"https:\/\/www.seamlessbio.de\/applications\/car-t-cell-manufacturing\">\u2192 CAR-T Cell Manufacturing Guide<\/a>\n      <a href=\"https:\/\/www.seamlessbio.de\/applications\/aav-viral-vector-production\">\u2192 AAV &amp; Viral Vector Production<\/a>\n      <a href=\"https:\/\/www.seamlessbio.de\/applications\/vaccine-production\">\u2192 Vaccine Production Guide<\/a>\n      <a href=\"https:\/\/www.seamlessbio.de\/products\/fetal-bovine-serum\/fbs-gamma-irradiated\">\u2192 FBS Gamma Irradiated \u226525 kGy<\/a>\n      <a href=\"https:\/\/www.seamlessbio.de\/products\/fetal-bovine-serum\/fbs-tet-free\">\u2192 FBS Tet-Free &lt;10 ng\/mL<\/a>\n      <a href=\"https:\/\/www.seamlessbio.de\/products\/fetal-bovine-serum\/fbs-low-very-low-endotoxin\">\u2192 FBS Low Endotoxin \u22641 EU\/mL<\/a>\n    <\/div>\n  <\/div>\n  <div class=\"hub-back\"><a href=\"https:\/\/www.seamlessbio.de\/applications\/\">\u2190 All Application Guides Overview<\/a><\/div>\n  <div class=\"cta\">\n    <h2>Pharmaceutical FBS \u2014 Documentation Package on Request<\/h2>\n    <p>Full Ph. Eur. specification, origin certificates, viral testing reports, TSE\/BSE statements and gamma irradiation certificates available per lot. Batch reservation 12\u201336 months for GMP programmes.<br>Email: info@seamlessbio.de | +49 851 37932226<\/p>\n    <div class=\"ctabtns\">\n      <a href=\"mailto:info@seamlessbio.de\" class=\"ctab1\">Request Documentation<\/a>\n      <a href=\"https:\/\/shop.seamlessbio.de\" class=\"ctab2\">View in Shop<\/a>\n    <\/div>\n  <\/div>\n<\/div>\n<script type=\"application\/ld+json\">\n{\n  \"@context\": \"https:\/\/schema.org\",\n  \"@graph\": [\n    {\n      \"@type\": \"FAQPage\",\n      \"@id\": \"https:\/\/www.seamlessbio.de\/applications\/fbs-for-pharma#faqpage\",\n      \"mainEntity\": [\n    {\n      \"@type\": \"Question\",\n      \"name\": \"Which FBS origin is preferred for EMA submissions?\",\n      \"acceptedAnswer\": {\n        \"@type\": \"Answer\",\n        \"text\": \"Australian and New Zealand origin FBS carries the strongest TSE\/BSE documentation for EMA submissions \u2014 both countries are classified as OIE Negligible Risk with no indigenous BSE. EDQM CEP is available for both origins. EU-origin FBS is also accepted and can simplify import documentation for DACH-based manufacturers. US-origin FBS (USDA 9CFR) is preferred for FDA IND\/BLA submissions.\"\n      }\n    },\n    {\n      \"@type\": \"Question\",\n      \"name\": \"How long can I reserve a pharmaceutical FBS lot?\",\n      \"acceptedAnswer\": {\n        \"@type\": \"Answer\",\n        \"text\": \"SeamlessBio offers batch reservation for 12\u201336 months for ATMP, GMP manufacturing, and clinical vaccine production programmes \u2014 covering the full journey from process development through Phase I\/II clinical batch production. This ensures the same lot specification throughout the campaign without risk of gap or lot change that would trigger process re-validation.\"\n      }\n    },\n    {\n      \"@type\": \"Question\",\n      \"name\": \"Is gamma-irradiated FBS required for GMP viral vaccine production?\",\n      \"acceptedAnswer\": {\n        \"@type\": \"Answer\",\n        \"text\": \"Gamma irradiation (\u226525 kGy) is not universally mandated but is increasingly specified for GMP viral vaccine production in BSL-2\/3 facilities to provide an additional assurance of viral safety beyond standard adventitious agent testing. SeamlessBio provides gamma-irradiated FBS with full dose mapping certificate and validation documentation per ISO 11137. This is also specified in some WHO and ICH Q5A-aligned FBS procurement guidelines.\"\n      }\n    },\n    {\n      \"@type\": \"Question\",\n      \"name\": \"Why is FBS Tet-Free needed for inducible expression systems?\",\n      \"acceptedAnswer\": {\n        \"@type\": \"Answer\",\n        \"text\": \"Standard FBS contains tetracycline residues at 10\u2013100 ng\/mL from routine antibiotic use in bovine husbandry. Tet-On and Tet-Off inducible promoter systems \u2014 used in AAV packaging cell lines, lentiviral vector production, and CAR-T construct systems \u2014 are suppressed by tetracycline at concentrations as low as 1\u201310 ng\/mL. Standard FBS can partially or completely suppress inducible transgene expression, causing researchers to incorrectly conclude their construct is non-functional. FBS Tet-Free &lt;10 ng\/mL is mandatory for any Tet-regulated application.\"\n      }\n    }\n      ]\n    },\n    {\n      \"@type\": \"BreadcrumbList\",\n      \"@id\": \"https:\/\/www.seamlessbio.de\/applications\/fbs-for-pharma#breadcrumb\",\n      \"itemListElement\": [\n        {\n          \"@type\": \"ListItem\",\n          \"position\": 1,\n          \"name\": \"Home\",\n          \"item\": \"https:\/\/www.seamlessbio.de\/\"\n        },\n        {\n          \"@type\": \"ListItem\",\n          \"position\": 2,\n          \"name\": \"Applications\",\n          \"item\": \"https:\/\/www.seamlessbio.de\/applications\/\"\n        },\n        {\n          \"@type\": \"ListItem\",\n          \"position\": 3,\n          \"name\": \"FBS for Pharmaceutical Applications\",\n          \"item\": \"https:\/\/www.seamlessbio.de\/applications\/fbs-for-pharma\"\n        }\n      ]\n    }\n  ]\n}\n<\/script>\n<\/section>\t\t\t\t<\/div>\n\t\t\n<\/div>\n\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Home\/ Applications\/ FBS for Pharmaceutical Use SeamlessBio \u2014 Ph. Eur. \u00b7 ICH Q5A \u00b7 GMP Documentation \u00b7 Batch Reservation Fetal Bovine Serum for Pharmaceutical Applications \u2014 Ph. Eur. &amp; EMEA [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_eb_attr":"","footnotes":""},"class_list":["post-1848","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>FBS GMP Ph. Eur. EMEA Australian US origin gamma irradiated<\/title>\n<meta name=\"description\" content=\"Pharmaceutical-grade FBS. US, Australian, NZ, EU origin. Ph. Eur. viral safety. Gamma irradiation, Tet-Free, Heat Inactivated.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/seamlessbio.de\/de\/fbs-for-pharma\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"FBS GMP Ph. Eur. EMEA Australian US origin gamma irradiated\" \/>\n<meta property=\"og:description\" content=\"Pharmaceutical-grade FBS. US, Australian, NZ, EU origin. Ph. Eur. viral safety. Gamma irradiation, Tet-Free, Heat Inactivated.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/seamlessbio.de\/de\/fbs-for-pharma\/\" \/>\n<meta property=\"og:site_name\" content=\"SeamlessBio\" \/>\n<meta property=\"article:modified_time\" content=\"2026-06-27T11:36:00+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Gesch\u00e4tzte Lesezeit\" \/>\n\t<meta name=\"twitter:data1\" content=\"4\u00a0Minuten\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/seamlessbio.de\\\/fbs-for-pharma\\\/\",\"url\":\"https:\\\/\\\/seamlessbio.de\\\/fbs-for-pharma\\\/\",\"name\":\"FBS GMP Ph. Eur. EMEA Australian US origin gamma irradiated\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/seamlessbio.de\\\/#website\"},\"datePublished\":\"2026-06-27T11:34:23+00:00\",\"dateModified\":\"2026-06-27T11:36:00+00:00\",\"description\":\"Pharmaceutical-grade FBS. US, Australian, NZ, EU origin. Ph. Eur. viral safety. Gamma irradiation, Tet-Free, Heat Inactivated.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/seamlessbio.de\\\/fbs-for-pharma\\\/#breadcrumb\"},\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/seamlessbio.de\\\/fbs-for-pharma\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/seamlessbio.de\\\/fbs-for-pharma\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Start\",\"item\":\"https:\\\/\\\/seamlessbio.de\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Application FBS for Pharma\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/seamlessbio.de\\\/#website\",\"url\":\"https:\\\/\\\/seamlessbio.de\\\/\",\"name\":\"SeamlessBio\",\"description\":\"Expert for biological materials for pharma, vaccines and research organizations\",\"publisher\":{\"@id\":\"https:\\\/\\\/seamlessbio.de\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/seamlessbio.de\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/seamlessbio.de\\\/#organization\",\"name\":\"SeamlessBio\",\"url\":\"https:\\\/\\\/seamlessbio.de\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/seamlessbio.de\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/seamlessbio.de\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/cropped-cropped-cropped-\u0438\u0437\u043e\u0431\u0440\u0430\u0436\u0435\u043d\u0438\u0435_2026-04-26_165903047.png\",\"contentUrl\":\"https:\\\/\\\/seamlessbio.de\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/cropped-cropped-cropped-\u0438\u0437\u043e\u0431\u0440\u0430\u0436\u0435\u043d\u0438\u0435_2026-04-26_165903047.png\",\"width\":309,\"height\":88,\"caption\":\"SeamlessBio\"},\"image\":{\"@id\":\"https:\\\/\\\/seamlessbio.de\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"FBS GMP Ph. Eur. EMEA Australian US origin gamma irradiated","description":"Pharmaceutical-grade FBS. US, Australian, NZ, EU origin. Ph. Eur. viral safety. Gamma irradiation, Tet-Free, Heat Inactivated.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/seamlessbio.de\/de\/fbs-for-pharma\/","og_locale":"de_DE","og_type":"article","og_title":"FBS GMP Ph. Eur. EMEA Australian US origin gamma irradiated","og_description":"Pharmaceutical-grade FBS. US, Australian, NZ, EU origin. Ph. Eur. viral safety. Gamma irradiation, Tet-Free, Heat Inactivated.","og_url":"https:\/\/seamlessbio.de\/de\/fbs-for-pharma\/","og_site_name":"SeamlessBio","article_modified_time":"2026-06-27T11:36:00+00:00","twitter_card":"summary_large_image","twitter_misc":{"Gesch\u00e4tzte Lesezeit":"4\u00a0Minuten"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/seamlessbio.de\/fbs-for-pharma\/","url":"https:\/\/seamlessbio.de\/fbs-for-pharma\/","name":"FBS GMP Ph. Eur. EMEA Australian US origin gamma irradiated","isPartOf":{"@id":"https:\/\/seamlessbio.de\/#website"},"datePublished":"2026-06-27T11:34:23+00:00","dateModified":"2026-06-27T11:36:00+00:00","description":"Pharmaceutical-grade FBS. US, Australian, NZ, EU origin. Ph. Eur. viral safety. Gamma irradiation, Tet-Free, Heat Inactivated.","breadcrumb":{"@id":"https:\/\/seamlessbio.de\/fbs-for-pharma\/#breadcrumb"},"inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["https:\/\/seamlessbio.de\/fbs-for-pharma\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/seamlessbio.de\/fbs-for-pharma\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Start","item":"https:\/\/seamlessbio.de\/"},{"@type":"ListItem","position":2,"name":"Application FBS for Pharma"}]},{"@type":"WebSite","@id":"https:\/\/seamlessbio.de\/#website","url":"https:\/\/seamlessbio.de\/","name":"SeamlessBio","description":"Experte f\u00fcr biologische Materialien f\u00fcr die Pharmaindustrie, Impfstoffe und Forschungseinrichtungen","publisher":{"@id":"https:\/\/seamlessbio.de\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/seamlessbio.de\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de"},{"@type":"Organization","@id":"https:\/\/seamlessbio.de\/#organization","name":"SeamlessBio","url":"https:\/\/seamlessbio.de\/","logo":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/seamlessbio.de\/#\/schema\/logo\/image\/","url":"https:\/\/seamlessbio.de\/wp-content\/uploads\/2026\/04\/cropped-cropped-cropped-\u0438\u0437\u043e\u0431\u0440\u0430\u0436\u0435\u043d\u0438\u0435_2026-04-26_165903047.png","contentUrl":"https:\/\/seamlessbio.de\/wp-content\/uploads\/2026\/04\/cropped-cropped-cropped-\u0438\u0437\u043e\u0431\u0440\u0430\u0436\u0435\u043d\u0438\u0435_2026-04-26_165903047.png","width":309,"height":88,"caption":"SeamlessBio"},"image":{"@id":"https:\/\/seamlessbio.de\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/seamlessbio.de\/de\/wp-json\/wp\/v2\/pages\/1848","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/seamlessbio.de\/de\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/seamlessbio.de\/de\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/seamlessbio.de\/de\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/seamlessbio.de\/de\/wp-json\/wp\/v2\/comments?post=1848"}],"version-history":[{"count":4,"href":"https:\/\/seamlessbio.de\/de\/wp-json\/wp\/v2\/pages\/1848\/revisions"}],"predecessor-version":[{"id":1852,"href":"https:\/\/seamlessbio.de\/de\/wp-json\/wp\/v2\/pages\/1848\/revisions\/1852"}],"wp:attachment":[{"href":"https:\/\/seamlessbio.de\/de\/wp-json\/wp\/v2\/media?parent=1848"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}